España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
IDEAYA Biosciences
IDYA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$25.30
-0.08
-0.32%
At close: -
$25.25
-0.05
-0.20%
After Hours: 1:00 PM EDT
Get Report
Comment
IDEAYA Biosciences (IDYA) Forecast
News
Earnings
IDEAYA Biosciences (IDYA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for IDEAYA Biosciences (NASDAQ:IDYA) Stock
IDEAYA Biosciences Stock (NASDAQ: IDYA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
Cantor Fitzgerald Reiterates Overweight on ID...
Benzinga Newsdesk
Wedbush Reiterates Outperform on IDEAYA Biosc...
Benzinga Newsdesk
The Independent Data Monitoring Committee Has...
Benzinga Newsdesk
Monday, December 16, 2024
Ideaya Biosciences Announced The Development ...
Benzinga Newsdesk
Tuesday, December 10, 2024
Ideaya Biosciences Has Dosed The First Patien...
Benzinga Newsdesk
Monday, December 09, 2024
IDEAYA Biosciences Unveils IDE892, A Promisin...
Benzinga Newsdesk
Monday, November 18, 2024
Stephens & Co. Initiates Coverage On IDEAYA B...
Benzinga Newsdesk
Friday, November 15, 2024
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
Avi Kapoor
Monday, November 11, 2024
IDEAYA Licenses Biocytogen's Antibody Program...
Benzinga Newsdesk
Tuesday, November 05, 2024
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor
Leerink Partners Downgrades IDEAYA Bioscience...
Benzinga Newsdesk
Monday, November 04, 2024
IDEAYA Biosciences Q3 2024 GAAP EPS $(0.60) B...
Benzinga Newsdesk
Tuesday, October 29, 2024
Oppenheimer Reiterates Outperform on IDEAYA B...
Benzinga Newsdesk
Monday, October 28, 2024
IDEAYA Biosciences Reveals Clearance Of Investigational New DrugApplication With FDA For Initiation Of Phase 1 Clinical Trial To Evaluate Werner Helicase Development Candidate IDE275
Suganya Shanmugam
Friday, October 25, 2024
IDEAYA Biosciences shares are trading higher ...
Benzinga Newsdesk
IDEAYA Biosciences Announces Phase 1 Expansio...
Nabaparna Bhattacharya
Thursday, October 24, 2024
UBS Initiates Coverage On IDEAYA Biosciences ...
Benzinga Newsdesk
Friday, October 04, 2024
IDEAYA Biosciences Announces Late-Breaker Ora...
Nabaparna Bhattacharya
Tuesday, September 24, 2024
Wedbush Maintains Outperform on IDEAYA Biosci...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on IDEAYA B...
Benzinga Newsdesk
Monday, September 23, 2024
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
Vandana Singh
Ideaya Biosciences shares are trading higher ...
Benzinga Newsdesk
Ideaya Biosciences Announced Interim Phase 2 ...
Benzinga Newsdesk
Reported Sunday, IDEAYA Biosciences to Announ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Stifel Maintains Buy on IDEAYA Biosciences, R...
Benzinga Newsdesk
Tuesday, August 27, 2024
Citigroup Maintains Buy on IDEAYA Biosciences...
Benzinga Newsdesk
Thursday, August 08, 2024
JP Morgan Maintains Overweight on IDEAYA Bios...
Benzinga Newsdesk
Wednesday, August 07, 2024
RBC Capital Reiterates Outperform on IDEAYA B...
Benzinga Newsdesk
Wedbush Reiterates Outperform on IDEAYA Biosc...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on IDEAYA Bi...
Benzinga Newsdesk
Tuesday, August 06, 2024
IDEAYA Biosciences Cash, Cash Equivalents And...
Benzinga Newsdesk
IDEAYA Biosciences Q2 2024 GAAP EPS $(0.68) M...
Benzinga Newsdesk
Wednesday, July 31, 2024
IDEAYA Biosciences Announced That It Has Ente...
Benzinga Newsdesk
Friday, July 12, 2024
JP Morgan Maintains Overweight on IDEAYA Bios...
Benzinga Newsdesk
Thursday, July 11, 2024
RBC Capital Maintains Outperform on IDEAYA Bi...
Benzinga Newsdesk
Wednesday, July 10, 2024
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
IDEAYA Biosciences shares are trading lower a...
Bill Haddad
Reported Earlier, IDEAYA Prices $263M Public ...
Benzinga Newsdesk
Tuesday, July 09, 2024
IDEAYA Biosciences shares are trading lower a...
Benzinga Newsdesk
IDEAYA Biosciences Intends To Offer Up To $20...
Benzinga Newsdesk
BTIG Maintains Buy on IDEAYA Biosciences, Rai...
Benzinga Newsdesk
Monday, July 08, 2024
Stifel Maintains Buy on IDEAYA Biosciences, M...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on IDEAYA Bi...
Benzinga Newsdesk
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
Vandana Singh
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
Avi Kapoor
IDEAYA Biosciences shares are trading higher ...
Benzinga Newsdesk
Mizuho Initiates Coverage On IDEAYA Bioscienc...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch